1. Home
  2. OLMA vs TVA Comparison

OLMA vs TVA Comparison

Compare OLMA & TVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • TVA
  • Stock Information
  • Founded
  • OLMA 2006
  • TVA 2024
  • Country
  • OLMA United States
  • TVA United States
  • Employees
  • OLMA N/A
  • TVA N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • TVA
  • Sector
  • OLMA Health Care
  • TVA
  • Exchange
  • OLMA Nasdaq
  • TVA Nasdaq
  • Market Cap
  • OLMA 299.7M
  • TVA 303.4M
  • IPO Year
  • OLMA 2020
  • TVA 2025
  • Fundamental
  • Price
  • OLMA $5.76
  • TVA $10.13
  • Analyst Decision
  • OLMA Strong Buy
  • TVA
  • Analyst Count
  • OLMA 5
  • TVA 0
  • Target Price
  • OLMA $24.00
  • TVA N/A
  • AVG Volume (30 Days)
  • OLMA 532.6K
  • TVA 122.0
  • Earning Date
  • OLMA 08-11-2025
  • TVA 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • TVA N/A
  • EPS Growth
  • OLMA N/A
  • TVA N/A
  • EPS
  • OLMA N/A
  • TVA N/A
  • Revenue
  • OLMA N/A
  • TVA N/A
  • Revenue This Year
  • OLMA N/A
  • TVA N/A
  • Revenue Next Year
  • OLMA N/A
  • TVA N/A
  • P/E Ratio
  • OLMA N/A
  • TVA N/A
  • Revenue Growth
  • OLMA N/A
  • TVA N/A
  • 52 Week Low
  • OLMA $2.86
  • TVA $9.99
  • 52 Week High
  • OLMA $13.93
  • TVA $10.34
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 63.92
  • TVA N/A
  • Support Level
  • OLMA $5.34
  • TVA N/A
  • Resistance Level
  • OLMA $5.78
  • TVA N/A
  • Average True Range (ATR)
  • OLMA 0.34
  • TVA 0.00
  • MACD
  • OLMA 0.05
  • TVA 0.00
  • Stochastic Oscillator
  • OLMA 85.90
  • TVA 0.00

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About TVA Texas Ventures Acquisition III Corp Class A Ordinary Share

Texas Ventures Acquisition III Corp is a blank check company.

Share on Social Networks: